A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Name: A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection
Published: 2013
License: Public Domain

AbbVie · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

hepatitis-c

hepatitis c virus infection, human immunodeficiency virus infection, chronic hepatitis c, compensated cirrhosis and non-cirrhotics, hcv genotype 4, interferon-free, hepatitis c genotype 1, compensated cirrhosis, hepatitis c genotype 4, hcv / hiv coinfection, cirrhotic, hepatitis c

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1047950
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.